$IFF

India's Competition Commission (CCI) is investigating Givaudan, dsm-firmenich, and International Flavors & Fragrances (IFF) for alleged price collusion in the fragrance industry, according to regulatory documents. The probe, separate from an ongoing anti-poaching case, was delayed after concerns over sensitive information. The companies face similar scrutiny in other markets and are cooperating. India's fragrance sector is expected to grow significantly.

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

International Flavors & Fragrances (IFF) has a stable analyst outlook. Barclays raised its price target to $90, maintaining an 'Overweight' rating. The average target is $94.44, implying a 15.4% upside, with the highest at $105, suggesting 28.3% potential gain.

Ana Paula Teles de Mendonca, President of Scent at International Flavors & Fragrances (IFF), sold 5,718 shares for $475,691 on August 17, 2026. IFF's Q2 2026 earnings and revenue missed estimates, but the company reported 6% sales and EBITDA growth, raised its full-year outlook, and announced a portfolio overhaul. Oppenheimer raised its price target to $95, maintaining an Outperform rating.

Teles de Mendonca Ana Paula (President, Scent) sold 5,718 shares of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) at $83.19 ($0.48M total) on 2026-08-17.

International Flavors & Fragrances (IFF) reported Q2 2026 revenue from continuing operations of $1.95 billion, up 6% currency-neutral, and adjusted EPS ex amortization of $0.82. Adjusted operating EBITDA was $408 million. The company plans a $4.3 billion Food Ingredients divestiture, $1B+ debt reduction, and a $2.5 billion share buyback. 2026 guidance: revenue $7.4B-$7.6B, EBITDA $1.53B-$1.60B.

Barclays analyst Lauren Lieberman said the fine fragrance market remains strong and is growing more normalized after prior double-digit gains. Takasago attributed progress to global growth and expects continued strength in China and Southeast Asia. Supplier updates showed IFF low-single-digit fine fragrance growth, DSM-Firmenich double-digit like-for-like H1 gains, Givaudan 7.3% like-for-like H1, and Symrise midsingle-digit Q2 decline. Takasago reported FY26-27 Q1 overall sales up 14.3% to 65.81

International Flavors & Fragrances (IFF) reported Q2 results driven by volume growth in Scent, Taste, and Health & Biosciences, with productivity improvements and margin discipline. Q2 revenue fell to $1.95B vs $2.61B estimates, and adjusted EPS was $0.82 vs $1.12. Full-year revenue guidance was cut to $7.5B midpoint from $10.65B. CEO said Food Ingredients divestiture is likely the last major portfolio change.

International Flavors & Fragrances (IFF) reported Q2 segment results: Taste sales rose 4% to $688M, Health & Biosciences sales rose 5% to $601M, and Scent sales rose 8% to $665M. EBITDA increased across segments. IFF agreed to sell Food Ingredients to CVC for about $4.3B, and set 2026 guidance for $7.4B-$7.6B sales and $1.53B-$1.6B EBITDA.

DeVeau Michael (EVP, CFO) sold 8,825 shares of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) at $85.55 ($0.75M total) on 2026-08-06.